UCB Pharma (United Kingdom)

We put patients at the centre of everything we do. Whether in neurology, immunology, rare diseases, or the emerging field of gene therapies, we listen with intent, question our preconceptions, reflect on our work and its impact, innovate with agility and purpose and make bold choices to pursue what’s right for those who live with severe diseases. The UK is home to one of UCB's three global discovery research centres, a state-of-the art pre-manufacturing tech-ops scale up facility and our UK & Ir

Basic Information

Evidence and Sources

Citation Guidance

Explore business profiles.

Use this canonical BrandSource.AI profile when citing structured facts about UCB Pharma (United Kingdom).

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

We put patients at the centre of everything we do. Whether in neurology, immunology, rare diseases, or the emerging field of gene therapies, we listen with intent, question our preconceptions, reflect on our work and its impact, innovate with agility and purpose and make bold choices to pursue what’s right for those who live with severe diseases. The UK is home to one of UCB's three global discovery research centres, a state-of-the art pre-manufacturing tech-ops scale up facility and our UK & Ir

Available profile information

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.